ARCTURUS THERAPEUTICS HOLDIN (ARCT) Stock Analyst Ratings
USA - NASDAQ:ARCT - US03969T1097 - Common Stock
8.67 USD
-0.11 (-1.25%)
8.67 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 81% to ARCT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 45.67. This target is 426.8% above the current price.
ARCT was analyzed by 17 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about ARCT.
In the last month the buy percentage fell by 6 points. So the trust of analysts is decreasing.
ARCT was analyzed by 17 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-11 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-11-11 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2025-10-24 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2025-10-23 | Guggenheim | Downgrade | Buy -> Neutral |
| 2025-10-23 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-10-23 | Citigroup | Downgrade | Buy -> Neutral |
| 2025-10-22 | Guggenheim | Downgrade | Buy -> Neutral |
| 2025-10-22 | BTIG | Maintains | Buy -> Buy |
| 2025-08-22 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2025-08-12 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-08-12 | Citigroup | Maintains | Buy -> Buy |
| 2025-07-02 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2025-05-28 | ScotiaBank | Initiate | Sector Outperform |
| 2025-05-14 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-05-13 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-04-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-10 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-03-07 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-03-07 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-03-07 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-02-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-28 | BTIG | Initiate | Buy |
| 2025-01-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-07 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-12-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-16 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-11-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-09 | Cantor Fitzgerald | Reiterate | Overweight |
ARCTURUS THERAPEUTICS HOLDIN / ARCT FAQ
What do analysts expect the price target to be for ARCTURUS THERAPEUTICS HOLDIN (ARCT)?
17 analysts have analysed ARCT and the average price target is 45.67 USD. This implies a price increase of 426.8% is expected in the next year compared to the current price of 8.67.
What is the consensus rating for ARCTURUS THERAPEUTICS HOLDIN (ARCT) stock?
The consensus rating for ARCTURUS THERAPEUTICS HOLDIN (ARCT) is 81.1765 / 100 . This indicates that analysts generally have a positive outlook on the stock.